National Lung Cancer Partnership Young Investigator Research Grant Competition
Application deadline October 22, 2013
This year, National Lung Cancer Partnership will award multiple two-year, $100,000 research grants to post-doctoral fellows and junior faculty in support of our vision to double lung cancer survival by 2022. The purpose of this Grant Program is to drive research forward that will lead to increasing survival rates for lung cancer patients, while ensuring that young investigators have the resources needed for them to succeed as lung cancer researchers.
Areas of Interest
Improving outcomes for patients with early stage cancer—proposals that have near-term potential to make a dramatic improvement in early stage cures. Strategies may include:
• Improving initial treatment response
• Preventing and/or overcoming resistance to treatment
• Preventing/predicting local recurrence
• Preventing/predicting metastases
•Biomarker validation to predict risk of recurrence or response to treatment
Improving outcomes for patients with unresectable lung cancer—proposals describing innovative strategies to address challenges in treating locally advanced, oligometastatic, and disseminated metastatic patients. Strategies may include:
• Preventing and/or treating CNS metastases
• Targeting oncogene-addicted pathways (new approaches for pathways with targeted agents; approaches for pathways without current targeted agents)
• Rational combination therapy design and delivery
• Biomarker validation for associated therapeutic benefit
• Developing new models of disease development or treatment that can be rapidly moved to clinical implementation
At the time of application, an applicant must hold a doctoral degree (MD, PhD, DO, DrPH, or equivalent), and be a post-doctoral fellow or be in the first five years of their first faculty appointment at a not-for-profit institution in the United States or Canada.
For questions, please contact Alice Yuroff, PhD, Senior Programs Manager.